Coronavirus Latest News

Coronavirus: BioNTech chooses Singapore as its Asia-Pacific vaccine hub

German drug maker BioNTech, whose coronavirus vaccine with Pfizer was the first to be approved in the United States and Europe for use last year, on Monday announced a new manufacturing facility in Singapore that would produce “several hundreds of millions” of mRNA-based vaccine doses a year.The move will boost BioNTech’s production capacities for vaccines and therapeutics for infectious diseases and cancer, and ensure it has rapid-response production capability for potential pandemic threats…

Read the original article at South China Morning Post

Related Articles

Back to top button